Metabolic-Fit / 100
MultiMedRx review
MultiMedRx publishes no medication price at all. The $100 on its homepage is "the $100 fully refundable consultation fee", and the "$45 to start" is an entry promotion — neither is what the medication costs, and the site never says. It does name its own billing period unusually plainly, though, calling it the "(4-Week monthly) program fee" in the same breath — four weeks, not a month, which is thirteen charges a year rather than twelve. Asked which states it serves, it answers: complete the intake form.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
MultiMedRx at a glance
- Semaglutide
- No medication price published anywhere
- Tirzepatide
- No medication price published anywhere
- Coverage
- Refuses to publish — "complete the patient intake form"
- Brand-name
- Compounded only
How we scored MultiMedRx
Every factor comes from MultiMedRx's own published pricing, disclosures and oversight, and the six combine into the 33/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- low
- Primary source
- multimedrx.com
Read from MultiMedRx's own pages in August 2026. It publishes no medication price at all: the $100 on its homepage is a fully refundable consultation fee and the "$45 to start" is an entry promotion, while the program fee that actually covers the medication is described but never stated. Its own FAQ calls that fee the "(4-Week monthly) program fee" — four weeks rather than a calendar month, which is thirteen billing cycles a year — and says it covers medication up to 10ml of tirzepatide or 2.5ml of semaglutide. Asked which states it serves, the site answers that you should complete the intake form. It publishes NPI numbers and two street addresses but names no operating entity.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $100 | Consultation fee only; no medication price published"Pay the $100 fully refundable consultation fee." This is NOT a medication price — the site never publishes one. The program fee is said to cover medication "up to 2.5 for Semaglutide" but is not itself stated. |
| Compounded tirzepatide | $100 | Consultation fee only; no medication price publishedSame refundable consultation fee. The program fee is said to cover "up to 10ml for Tirzepatide", again without stating the fee. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what MultiMedRx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- The $100 consultation fee is described as fully refundable, and that is stated up front rather than buried
- Says plainly what the program fee covers — medication "up to 10ml for Tirzepatide and 2.5 for Semaglutide"
- "You don't need to sign a long-term contract", with a one-month option available
- Publishes NPI numbers and two street addresses, in Newport Beach and Reno
- Offers metformin, testosterone and hormone replacement alongside the GLP-1s
The caveats
- No medication price appears anywhere on the site — the program fee is described but never stated
- The $100 is a consultation fee and the $45 an entry promotion; neither is a monthly cost
- The billing period is four weeks, not a month — the site's own phrase is "(4-Week monthly) program fee", which is thirteen billing cycles a year
- It will not publish which states it serves: "To find out if we're available in your state, simply complete the patient intake form"
- The medication allowance is capped by volume — 10ml of tirzepatide, 2.5ml of semaglutide — so a higher dose may exhaust it
- No operating entity is named anywhere
MultiMedRx for mothers: our verdict
MultiMedRx publishes no medication price at all. The $100 on its homepage is "the $100 fully refundable consultation fee", and the "$45 to start" is an entry promotion — neither is what the medication costs, and the site never says. It does name its own billing period unusually plainly, though, calling it the "(4-Week monthly) program fee" in the same breath — four weeks, not a month, which is thirteen charges a year rather than twelve. Asked which states it serves, it answers: complete the intake form.
We weigh MultiMedRx the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What MultiMedRx costs, in full
- Compounded semaglutide — Consultation fee only; no medication price published: $100/4 wks
- Compounded tirzepatide — Consultation fee only; no medication price published: $100/4 wks
The medications MultiMedRx prescribes
MultiMedRx prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where MultiMedRx fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence here is limited: what MultiMedRx publishes is thin or self-contradictory in places, so parts of the picture are not settled — treat the figures below as its own claims until you have them in writing. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
MultiMedRx is a provider we can only partly verify — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Hard to say without a medication price, which the site does not provide.
Alternatives to MultiMedRx
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing MultiMedRx
Head-to-head & alternatives
MultiMedRx, answered
- How much does MultiMedRx cost?
- MultiMedRx doesn't post a standard monthly cash price — pricing depends on insurance or appears after an intake. Get a written quote and confirm the ongoing rate before committing.
- Is MultiMedRx safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. MultiMedRx is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does MultiMedRx offer both semaglutide and tirzepatide?
- Yes — MultiMedRx offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does MultiMedRx rank for mothers?
- MultiMedRx scores 33/100 on our Metabolic-Fit Score and sits at #262. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect MultiMedRx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.